DigestRedComo funciona
Red
/
Empresas
Ka
No verificado

Kairos Pharma, Ltd

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaOncologíaSalud

30 Comunicados de prensa

Ver todos los comunicados de prensa
04/06/2026
Oncología
Salud
Medicina - Varios
Ciencia
Biotecnología
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
14/05/2026
Eventos
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma Receives GHP Magazine’s Healthcare & Pharmaceutical Award
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
08/05/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
15/04/2026
Eventos
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
02/03/2026
Mercado laboral
Software
Biotecnología
Farmacéutica
Oncología
Salud
Técnica
Medicina - Varios
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
26/02/2026
Mercado de valores
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
20/01/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Kairos Pharma to Present at 3rd Annual DealFlow Discovery Conference
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
17/12/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
20/10/2025
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
07/10/2025
Salud
Ciencia
Farmacéutica
Oncología
Eventos
Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0